Cdc2 p34 Antibody (Y100.4) is a mouse monoclonal IgG2b antibody that detects Cdc2 p34 in mouse, rat, and human samples through applications such as western blotting (WB) and immunoprecipitation (IP). Cdc2 p34, also known as cyclin-dependent kinase 1 (CDK1), plays a crucial role in regulating the cell cycle, particularly the transition from the G2 phase to mitosis. Cdc2 p34 is essential for proper cell cycle progression, activating cyclins necessary for mitosis initiation. Various mechanisms, including phosphorylation and cyclin binding, tightly control Cdc2 p34 activity to ensure cells divide only when ready. Dysregulation of Cdc2 p34 can lead to uncontrolled cell proliferation, a hallmark of cancer, making Cdc2 p34 a significant target for therapeutic intervention. Anti-Cdc2 p34 antibody (Y100.4) serves as an invaluable tool for researchers studying cell cycle dynamics and molecular mechanisms underlying cell division.
Ordering Information
Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Cdc2 p34 Antibody (Y100.4) | sc-53217 | 200 µg/ml | $316.00 | |||
Cdc2 p34 Antibody (Y100.4): m-IgG Fc BP-HRP Bundle | sc-536909 | 200 µg Ab; 10 µg BP | $354.00 | |||
Cdc2 p34 Antibody (Y100.4): m-IgGκ BP-HRP Bundle | sc-534082 | 200 µg Ab; 40 µg BP | $354.00 |